BioSpace News Archive

CordenPharma announced the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. in Switzerland, and Corden Pharma Lisbon S.A. in Portugal.

Orphalan SA, a Company that identifies, develops, and delivers therapies worldwide for orphan diseases, announces two new appointments to the management team.

Centogene N.V., a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced the Company’s Supervisory Board’s nomination of Kim Stratton as Chief Executive Officer, transitioning from her prior designation as Interim CEO.

Exact Sciences Corp. announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

KARL STORZ Endoscopy-America, Inc., a leader in endoscopic imaging and related minimally invasive surgical systems, announced that Sonal Matai has been appointed Managing Director.

LAVA Therapeutics N.V., an immuno-oncology company focused on developing its proprietary Gammabody™ platformof bispecific gamma delta T cell engagers to transform the treatment of cancer, announced dosing of the first patient in the company’s Phase 1/2a clinical trial of LAVA-1207 in patients with metastatic castration-resistant prostate cancer.

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel irreversible small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, announced the appointment of Steve Morris, M.D. as Chief Medical Officer.

Indegene, a technology-led healthcare solutions provider announced the appointment of Pankaj Kakkar, former Head of Healthcare Provider Delivery at Tech Mahindra to strengthen its Global Operations.

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2021 .

Karuna Therapeutics, Inc. announced that senior management will participate in the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 10:00 a.m. ET.